Parke Davis: Uncertainty affects valuation - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Parke Davis: Uncertainty affects valuation

Dec 20, 2000

That international mergers create uncertainty is a given. This holds good for the management, the employees as well as the shareholders. A recent example is that of Parke Davis. The company till recently was an affiliate of the $ 9 bn Warner Lambert which held 40% in its Indian arm. The takeover of Warner Lambert by Pfizer and the presence of a two parallel 100% subsidiaries in India has led to a uncertainty about the prospects of Parke Davis and this has affected the valuation of the company.

International media reports have mentioned that Pfizer has cleared out several layers of Warner Lambert management leaving hardly any senior positions for the Warner Lambert staff as it consolidates its acquisition. What way the merger pans out in India remains to be seen.

In India, Parke Davis has a presence in gynaec care, cardiac care, pediatric care and neuro care. It’s cough syrup Benadryl is the third largest brand in the Rs 4.8 bn cough and colds market after Corex (Pfizer) and Phensedyl (Rhone Poulenc). Its over–the–counter products include Waterbury’s Compound (a health tonic), Gelusil (an antacid), Neko (a bath soap) and Listerine (an oral hygiene product). These contributed nearly 20% to the company’s turnover of Rs 1,793 m last year.

Over the past two years Parke Davis also launched products such as Walcillin (an amoxycillin based antibiotic), Atpark (cardiovasdcular) and Calcal (a calcium supplement). Though these products are based on much older molecules, they have done well and account for almost 12% of the company’s sales.

Last year the company sold its Saki Naka plant (in Mumbai) for Rs 493 m. However, the company has still not received the full payment for the same. (The workers of the plant were paid off via a Voluntary Retirement Scheme.)

Also, the company does not have a reputation for being minority shareholder friendly. A prominent example was the transfer, in the past, of cough lozenges ‘Halls’ and ‘Chiclets’ to the 100% subsidiary of its parent Warner Lambert India.

Coming to the financials, the company reported a 15% growth in its net profit in the first half of the current year. The write off of VRS expenditure was completed last year and this has led to a higher tax payment in the current year. At the current price of Rs 267, the stock price implies an earning multiple of 17 times its annualised earnings of FY01. This is relatively lower than the earnings multiples enjoyed by its peers. Keeping in mind the uncertainty regarding the merger and the way Pfizer has gone about the management changes, we don’t expect a favourable ratio for Parke Davis.

Equitymaster requests your view! Post a comment on "Parke Davis: Uncertainty affects valuation". Click here!


More Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

Krsnaa Diagnostics IPO Opens Tomorrow: Key Points to Consider (Views On News)

Aug 3, 2021

Krsnaa Diagnostics grey market premium is at around Rs 440 from its issue price of Rs 933-954.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles (Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Dec 7, 2021 02:59 PM